Dave Rushton
Founder
of Paradigm Shift Consulting Limited.
Dave Rushton is Founder of Paradigm Shift Consulting Limited, a Good Distribution Practice Consultancy.
Registered Office: Paradigm Shift Consulting Ltd,The Old Mill, 9 Soar Lane,Leicester, LE3 5DE, United Kingdom
0330 133 0920
If you’re a UK wholesale distributor of medicinal products, maintaining compliance with Good Distribution Practice (GDP) is not just a regulatory obligation, it is a core part of safeguarding patient safety and product integrity.
GDP guidelines, issued by the European Commission and enforced by the Medicines and Healthcare products Regulatory Agency (MHRA), aim to ensure that the quality of medicines is protected throughout the entire supply chain.
One essential GDP requirement outlined in Chapter 5 of the EU GDP Guidelines (2013/C 343/01) is the need for due diligence checks on your suppliers and outsourced activity providers. One method of due diligence is conducting external audits also known as second-party audits, as part of your supplier or provider qualification and monitoring processes.
External audits (also referred to as second-party audits) are assessments performed by you or on your behalf, on suppliers or third-party service providers (such as storage and transportation companies). These audits are different from internal (first-party) audits because they extend your compliance oversight outside your organisation, helping you manage risks across your supply chain.
A well-conducted second-party audit enables you to:
This process should be overseen by the Responsible Person (RP) or another suitably qualified and trained member of the quality team. If expertise is lacking internally, outsourcing to experienced GDP audit consultants such as Paradigm Shift Consulting can provide an objective and thorough approach while meeting regulatory expectations.
External audits are more than just a box-ticking exercise. They are a powerful tool for risk management and regulatory preparedness.
Here’s why they matter:
Many companies assume a signed Quality/Technical Agreement (QTA) alone is enough to ensure compliance. However, the QTA should be supported by tangible evidence, such as audit reports, showing that the agreed standards are being met in practice.
The frequency of external audits should follow a risk-based approach, taking into consideration:
Best practice recommendations include:
This periodic and proactive audit cycle not only satisfies GDP but also future-proofs your compliance against unexpected MHRA inspections.
To make your external audits meaningful and effective:
External audits are a valuable tool in your GDP compliance and supplier qualification programme.
They provide essential oversight, protect your business from downstream compliance risks, and help you to build confidence in your supply chain.
Failing to uncover external supplier/service provider related deficiencies can leave you exposed to serious consequences, including MHRA inspection findings, license variation or suspension, and loss of product integrity. Even seemingly minor non-conformances, if undetected, can lead to costly deviations, complaints, and/or affect your business reputation.
By embedding a structured, risk-based external audit programme into your quality system, you position your organisation not just for compliance, but for excellence in safeguarding public health.
If you need guidance or assistance on how to conduct external, second-party audits, or would like one of our CQI qualified lead auditors to perform an audit on your behalf, email us at: info@paradigmshiftconsulting.co.uk.